English English
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Podcasts

WFH Gene Therapy Registry

Presented by Barbara A. Konkle, MD and Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

Lentivirus Vectors for Hemophilia Gene Therapy

Presented by Glenn F. Pierce, MD, PhD and Robert Peters, PhD

HTC Readiness: A Multidisciplinary Perspective

Presented by Steven W. Pipe, MD and Debra Pollard, RN

HTC Readiness: A Global Perspective

Presented by Steven W. Pipe, MD and Debra Pollard, RN

Latest Advances in Gene Therapy for Hemophilia in Portuguese

Presented by Margareth Ozelo, MD, PhD

What Do Hemophilia Treatment Centers Need to Consider Now in Preparation for the Anticipated Availability of Gene Therapy?

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Hemophilia Gene Therapy in Patients With History of Inhibitors

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Laboratory Measurement of Hemophilia Gene Therapy Products/Factor Activity

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Interpreting Vector Doses in Hemophilia Gene Therapy Clinical Trials

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Part 1: Pre-existing Immunity Against AAV Serotypes and What This Means for Hemophilia Gene Therapy Clinical Trials

Presented by Steven W. Pipe, MD and Nigel Key, MB, ChB. FRCP

Back To Top
Image

Please enable the javascript to submit this form

About

Supported by educational grants from Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, and uniQure, Inc.

Essential SSL